All companies in which we invest have several traits in common, including outstanding management teams with relevant industry experience, large addressable markets, solid science, and strong intellectual property.
Stage of financing
We prefer to invest in seed or early-stage financings, but select later-stage financings will also be considered.
We will invest only in biotechnology and medical device companies. We are especially interested in product solutions for musculoskeletal disease.
We are focused on investment opportunities in the underserved markets of the Southeast and Midwest, but will consider investments outside these regions in some circumstances.